ANTARES PHARMA, INC. (ATRS) [Rocket]

Date Filed	Type	Description
04/27/2021	GN	Antares Pharma to Report First Quarter 2021 Financial and Operating Results
04/26/2021	GN	Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
03/02/2021	GN	Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results
02/24/2021	GN	Antares Pharma to Present at Two Upcoming Investor Conferences
02/23/2021	GN	Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results
02/17/2021	GN	Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference
11/23/2020	GN	Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
11/10/2020	GN	Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
10/22/2020	GN	Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
10/01/2020	GN	Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
08/10/2020	GN	Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
08/06/2020	GN	Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance
07/21/2020	GN	First Commercial Product Using Antares Pharma's Multi-Dose Pen Platform Launches in Europe
07/20/2020	GN	Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial
06/11/2020	GN	Antares Pharma to Present at the Raymond James Human Health Innovation Conference
05/27/2020	GN	Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
04/28/2020	GN	Antares Pharma to Report First Quarter 2020 Operating and Financial Results
03/03/2020	GN	Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results
02/26/2020	GN	Antares Pharma to Present at the Cowen and Company 40th Annual Health Care Conference
02/25/2020	GN	Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results
12/10/2019	GN	Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development
12/06/2019	GN	Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award
11/27/2019	GN	Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference
11/19/2019	GN	REMINDER: Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
11/19/2019	GN	Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
11/13/2019	GN	Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference